NCT03798912 - A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 9, 2019

Primary Completion Date

February 17, 2020

Study Completion Date

February 17, 2020

Conditions

Healthy Volunteers

Interventions

COMBINATION_PRODUCT

RaniPill capsule containing octreotide

Administration of a RaniPill capsule loaded with 100 mcg of octreotide. Serial blood samples will be collected over the following 4 h for pharmacokinetic analysis of octreotide a) injected intravenously and b) delivered directly into the jejunal wall by the RaniPill capsule.

Trial Locations (1)

Unknown

Nucleus Network, Melbourne